Mostafa Faisal Mohammed Saleh: Managing Severe Aplastic Anemia in Pregnancy After allo-HSCT
Mostafa Faisal Mohammed Saleh, Associate Professor of Clinical Hematology and HSCT at Assiut University, shared a post on LinkedIn about recent article he and his colleagues co-authored, published in Immuno, adding:
“Excited to share our recent case report on managing severe aplastic anemia during pregnancy after prior allo-HSCT.
A challenging case of relapsed SAA was managed with:
- Eltrombopag
- Cyclosporine
- G-CSF
- Repeated stem cell boosts
Successful delivery of a healthy infant was achieved with close multidisciplinary care and careful maternal–fetal monitoring.
This report highlights the potential role of TPO receptor agonists in highly selected refractory SAA pregnancies when conventional options are limited.
Grateful to all co-authors and collaborators, especially Dr Mahmoud Aljurf, Abdulrahman Nasiri and the Adult Hematology, Transplantation and Cellular Therapy team at KFSHRC.”
Title: Use of Thrombopoietin Receptor Agonists in Severe Aplastic Anemia During Pregnancy: A Case Report
Authors: Mostafa F. Mohammed Saleh, Ahemd Kotb Abrabou, Abdulrahman Nasiri, Alfadil Haroon, Mahmoud Aljurf

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 02:38Brianne D.: Sex Differences in RIPK1 Signaling Following Intracerebral Hemorrhage
-
Oct 10, 2026, 02:17Dino Mehic: Managing Heavy Menstrual Bleeding in Patients with BDUC
-
Oct 10, 2026, 00:34Raphaëlle Dodart: Discussing the Mechanisms of Menstrual Hemostasis
-
Oct 10, 2026, 00:26Barbara Adams Krolak: Discussing the Growing Need for Blood Clot Prevention in Asia
-
Oct 9, 2026, 23:59Ana Pedrero Gil: Is Coagulopathy with Fibrinolysis Present in All Obstetric Hemorrhages?
-
Oct 9, 2026, 23:57Exploring the Psychosocial Needs of People with Bleeding Disorders in Kyrgyzstan – EAHAD
-
Oct 9, 2026, 23:53Bernard Slater Jr.: Serving on the Advisory Council for the NBDF West Virginia Chapter
-
Oct 9, 2026, 23:53Aurelio Maggio: Thalassemia Reports Real-Time Impact Factor Rises to 1.760
-
Oct 9, 2026, 23:52Stronger Connections, Stronger Organizations – World Federation of Hemophilia